Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PODD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePODDInsulet$157.90+2.4%$207.40$148.30▼$354.88$10.95B1.21.10 million shs335,087 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePODDInsulet+0.01%-11.92%-21.71%-38.92%-50.34%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePODDInsulet$157.90+2.4%$207.40$148.30▼$354.88$10.95B1.21.10 million shs335,087 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePODDInsulet+0.01%-11.92%-21.71%-38.92%-50.34%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePODDInsulet 2.72Moderate Buy$257.0962.82% UpsideCurrent Analyst Ratings BreakdownLatest PODD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2026PODDInsulet BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy5/7/2026PODDInsulet The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$237.005/7/2026PODDInsulet Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$325.00 ➝ $280.005/7/2026PODDInsulet Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$315.00 ➝ $250.005/7/2026PODDInsulet Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$330.00 ➝ $200.005/7/2026PODDInsulet BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderweight$286.00 ➝ $198.005/7/2026PODDInsulet Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price Target$350.00 ➝ $250.005/7/2026PODDInsulet Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price Target$355.00 ➝ $263.005/7/2026PODDInsulet EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price Target$240.00 ➝ $200.005/7/2026PODDInsulet Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$435.00 ➝ $249.00(Data available from 5/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPODDInsulet$2.71B4.04$6.48 per share24.38$21.54 per share7.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePODDInsulet$247.10M$4.3036.7719.711.2510.44%26.87%12.01%N/ALatest PODD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026PODDInsulet$1.19$1.42+$0.23$1.30$729.89 million$761.70 million2/18/2026Q4 2025PODDInsulet$1.48$1.55+$0.07$1.44$768.31 million$783.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthPODDInsuletN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPODDInsulet0.712.491.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPODDInsuletN/AInsider OwnershipCompanyInsider OwnershipPODDInsulet0.36%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePODDInsulet5,40069.26 million69.02 millionOptionablePODD HeadlinesRecent News About These CompaniesHere's Why Insulet (PODD) is a Strong Growth Stock1 hour ago | zacks.comInsulet (NASDAQ:PODD) Shares Unloaded Sen. Tina SmithMay 12 at 2:13 AM | marketbeat.comSen. Tina Smith Sells Insulet Corporation (NASDAQ:PODD) StockMay 12 at 2:13 AM | marketbeat.comWhy Insulet (PODD) is a Top Value Stock for the Long-TermMay 11 at 10:40 AM | zacks.comInsulet establishes Middle East regional headquarters in Riyadh, marking a strategic milestone in the KingdomMay 11 at 7:54 AM | zawya.comZKatamaran Capital LLP Takes Position in Insulet Corporation $PODDMay 11 at 6:41 AM | marketbeat.comC WorldWide Group Holding A S Sells 10,000 Shares of Insulet Corporation $PODDMay 11 at 4:31 AM | marketbeat.comJefferies Financial Group Cuts Insulet (NASDAQ:PODD) Price Target to $360.00May 10 at 3:44 AM | americanbankingnews.comCitigroup Cuts Insulet (NASDAQ:PODD) Price Target to $175.00May 10 at 3:44 AM | americanbankingnews.comStifel Nicolaus Cuts Insulet (NASDAQ:PODD) Price Target to $250.00May 10 at 3:44 AM | americanbankingnews.comCanaccord Genuity Group Cuts Insulet (NASDAQ:PODD) Price Target to $249.00May 10 at 3:44 AM | americanbankingnews.comLeerink Partners Cuts Insulet (NASDAQ:PODD) Price Target to $247.00May 10 at 3:44 AM | americanbankingnews.comRobert W. Baird Cuts Insulet (NASDAQ:PODD) Price Target to $248.00May 10 at 3:44 AM | americanbankingnews.comRaymond James Financial Cuts Insulet (NASDAQ:PODD) Price Target to $263.00May 10 at 3:44 AM | americanbankingnews.comOppenheimer Cuts Insulet (NASDAQ:PODD) Price Target to $210.00May 10 at 3:44 AM | americanbankingnews.comEvercore Cuts Insulet (NASDAQ:PODD) Price Target to $200.00May 10 at 3:44 AM | americanbankingnews.comSwedbank AB Buys 8,500 Shares of Insulet Corporation $PODDMay 9 at 7:26 AM | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Purchases 8,172 Shares of Insulet Corporation $PODDMay 9 at 5:42 AM | marketbeat.comWells Fargo & Company Cuts Insulet (NASDAQ:PODD) Price Target to $255.00May 9 at 4:50 AM | americanbankingnews.comPiper Sandler Cuts Insulet (NASDAQ:PODD) Price Target to $210.00May 9 at 4:50 AM | americanbankingnews.comInsulet (NASDAQ:PODD) Stock Rating Upgraded by Wall Street ZenMay 9 at 2:41 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePODD Company DescriptionsInsulet NASDAQ:PODD$157.90 +3.73 (+2.42%) As of 12:14 PM Eastern This is a fair market value price provided by Massive. Learn more.Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Sony's $4 Billion Bet on Rock & Roll Royalties Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It AI Demand Fuels Strong Q1 Earnings for Constellation Energy TMC Forges a New EV Supply Chain at the Bottom of the Sea MercadoLibre Boldly Invests in Growth: Discount Deepens Manic Monday.com: The Rally Is Just the Beginning for this SaaS Leader 5 Stocks Positioned to Benefit From the AI Inference Boom Sell in May and Go Away—Starting With These 3 Stocks Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
